Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Equal Weight ETF ROE Celebrates Key Three Year ETF Milestone

BY | ETF Database
08/07/2026 | 18 VIEWS
  • Related Symbols
  • ROE
The ETF landscape has plenty of ways to signal momentum or positive news for ETFs, from tech charts to raw performance data. One key data point, however, is the three year anniversary of a fund’s launch. That not only shows a fund can operate successfully, but also, crucially, gets it onto numerous brokerages and in front of more investors. The Astoria US Equal Weight Quality Kings ETF (ROE B+) just hit its own such milestone this month.Key Takeaways: ROE launched three years ago and has returned 22.25% since inception, per a press release. The strategy charges a 49 bps fee for an equal weight approach to high quality stocks. Having returned 24% YTD, it continues to perform well amid rising concentration risk. ROE launched back on August 1st, 2023, and charges a 49 basis point (bps) fee to actively invest in 100 high quality U.S. stocks. In doing so, the active equal weight ETF looks for long term capital appreciation, using quantitative screens to craft an equal weight portfolio. “Three years in, ROE has done exactly what we designed it to do: deliver core US equity exposure without the concentration risk of the mega-caps, while letting quality stock selection drive the differentiation,” said John Davi, CEO, CIO, and Founder of Astoria Investment Management and Lead Portfolio Manager of the Fund.” ROE has performed well by mining for alpha within beta” The fund looks for strong numbers across metrics like quality, valuation, growth, and dividend potential. Furthermore, in evaluating securities, it also looks at factors like ROE, price-to-earnings ratio, and earnings momentum. That has seen the active equal weight ETF produce robust returns as it has hit its stride as a fund. ROE returned 36.1% over the last twelve months according to ETF Database data. That outperformed the fund’s ETF Database All Cap Equities category average, which comes in at 22.6% for that period. See more: Invest in Humanity & Get Rewarded With FTHF ROE has also outperformed that category average on a YTD and three year basis, too. Over the last three years, per ETF Database, ROE has returned 22.06% to the All Cap Equities category average of 10.6%. Meanwhile, since January 1st, ROE has returned 24%, compared to 14.9% for the average. Those numbers may speak to the merit of that equal weight ETF approach. While it does have exposure to major names like Amazon (AMZN), none of its equity weights exceed 1.5%. What’s more, it is also diversified, with names like Tenet Health Care (THC) also present and performing well. Now, hitting that three year milestone, ROE could be poised for new interest. As investors look to deal with concentration risk, an active equal weight strategy like ROE could be one to watch. For more news, information, and analysis, visit the Equity ETF Content Hub.

More Commentary

How the ETF Wrapper Unlocks Energy Stocks in FENY
BY | ETF Database
08/07/2026 | 33 VIEWS
Midstream Companies Expand Natural Gas Pipelines as LNG & AI Demand Grows
BY | ETF Database
08/07/2026 | 18 VIEWS
If ASML Is Awesome Again, This ETF Could Surge
BY | ETF Database
08/07/2026 | 44 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.